Download
Riedel_BIPS_27868277_Postprint.pdf 546,81KB
WeightNameValue
1000 Titel
  • Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011
1000 Autor/in
  1. Schröder, Carsten |
  2. Dörks, Michael |
  3. Kollhorst, Bianca |
  4. Blenk, Tilo |
  5. Dittmann, Ralf W. |
  6. Garbe, Edeltraut |
  7. Riedel, Oliver |
1000 Erscheinungsjahr 2016
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2016-11-20
1000 Erschienen in
1000 Quellenangabe
  • 26(2):170-179
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2016
1000 Embargo
  • 2017-11-20
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1002/pds.4138 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • PURPOSE: Recent studies on the utilization of antidepressant drugs in minors are scarce, methodologically limited, and do not factor in off‐label use sufficiently. Beyond that, little is known about the short treatment durations that have been observed for many young antidepressant users. The present study examined antidepressant use in pediatric patients aged 0 to 17 years over time, investigated changes regarding the prescribed drugs, analyzed underlying diagnoses, and assessed the rate of off‐label use. METHODS: We used claims data of roughly two million individuals to calculate annual prevalence and incidence rates of antidepressant prescriptions for the years 2004 to 2011. Analyses were stratified by age, sex, and drug type. For antidepressant users, numbers of prescriptions, frequencies of disorders/diseases, and specialties of the prescribing physicians were examined. The share of off‐label prescriptions was calculated for each year. RESULTS: The prescription prevalence of antidepressants ranged between 1.7 and 2.1 per 1000 minors. The use of tricyclic antidepressants decreased from 0.9 to 0.6 prescriptions per 1000 minors, while the use of selective serotonin reuptake inhibitors increased from 0.5 to 1.1. Of the patients with an antidepressant prescription, 46.4% only received one prescription. Depression was by far the most frequent diagnosis among all antidepressant users as well as among subjects with only one prescription. In 2011, 36.3% of all prescriptions were off‐label. CONCLUSION: The high proportion of single prescriptions, even in patients with a diagnosed depression, and the high rate of off‐label use are particularly noteworthy and should be further investigated in future studies.
1000 Sacherschließung
lokal Epidemiology
lokal Children
lokal SSRI
lokal Pharmacoepidemiology
lokal TCA
lokal Antidepressants
lokal Off‐label use
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2NocsO2ZGVyLCBDYXJzdGVu|https://frl.publisso.de/adhoc/uri/RMO2cmtzLCBNaWNoYWVs|https://frl.publisso.de/adhoc/uri/S29sbGhvcnN0LCBCaWFuY2E=|https://frl.publisso.de/adhoc/uri/QmxlbmssIFRpbG8=|https://frl.publisso.de/adhoc/uri/RGl0dG1hbm4sIFJhbGYgVy4=|https://frl.publisso.de/adhoc/uri/R2FyYmUsIEVkZWx0cmF1dA==|https://orcid.org/0000-0002-1721-502X
1000 Label
1000 Förderer
  1. German Federal Institute for Drugs and Medical Devices (BfArM) |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
  1. Nutzungsvereinbarung
  2. Wiley Self-Archiving Policy
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer German Federal Institute for Drugs and Medical Devices (BfArM) |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6416925.rdf
1000 Erstellt am 2019-10-18T15:20:54.119+0200
1000 Erstellt von 266
1000 beschreibt frl:6416925
1000 Bearbeitet von 266
1000 Zuletzt bearbeitet Thu Jan 30 17:38:19 CET 2020
1000 Objekt bearb. Tue Nov 05 11:49:35 CET 2019
1000 Vgl. frl:6416925
1000 Oai Id
  1. oai:frl.publisso.de:frl:6416925 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source